𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A test dose of I.V. busulfan (BU) is predictive of the area under the curve (AUC) of a single daily dose of I.V. bu in pediatric patients undergoing a reduced intensity (RI) hematopoietic stem cell transplant (HSCT)

✍ Scribed by M. Kletzel; D. Jacobsohn; R. Duerst

Book ID
116277648
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
70 KB
Volume
10
Category
Article
ISSN
1083-8791

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

229: Twice-Daily Intravenous (IV) Busulf
229: Twice-Daily Intravenous (IV) Busulfan (Bu) x 4 Days in Children Undergoing a Reduced-Intensity Conditioning (RIC) Regimen with Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) is Safe and Well-Tolerated but Results in Significantly Increased Bu Clearance (CL) and Decreased Area Under the Curve (AUC) and Half-Life (t1/2) When Compared to IV Bu Twice-Daily Dosing Pharmacokinetics (PK) in Adults
✍ I. Waxman; M. Bhatia; M. Milone; L.M. Shaw; L. Baldinger; O. Militano; J. Garvin πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier Science 🌐 English βš– 60 KB
Identification of an AUC of 7603 Umolβˆ—Mi
Identification of an AUC of 7603 Umolβˆ—Min/Hr Per Day X 4 Days as the Maximum Tolerated Dose (MTD) of IV Continuous Infusion (CI) Busulfan (BU) with Fixed Dose Fludarabine (FLU) in A Pharmacokinetically-Based Dose Phase I Study in Patients (PTS) with Hematologic Malignancies Undergoing Allogeneic Stem Cell Transplantation
✍ W.A. Wood; C.M. Walko; K.V. Rao; J. Whitley; D.T. Moore; D.A. Gabriel; J.S. Sero πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 45 KB